NCT06219291

Brief Summary

Motor performance of people with Multiple Sclerosis (PwMS) can decline since the onset of the disease. Longitudinal studies are needed to detect early worsening in mobility and balance using wearable devices for activity tracking and neurophysiological techniques for investigating brain functional adaptation. Similarly, neurophysiological assessment can provide evidences on the integrity of brain motor networks and mechanisms underlying cortical plasticity in the early disease phase, potentially providing a set of reliable prognostic factors of disease progression in early diagnosed PwMS. Furthermore, disease progression might be delayed using physical activity, which is effective in PwMS with moderate disability to ameliorate mobility and promoting brain reorganization and seems promising also for PwMS in the early stages of the disease. Functional Near-Infrared Spectroscopy (fNIRS) measures blood flow which accompanies neuronal activity, thus, it can provide spatial information about changes in cortical activation patterns and it could represent a useful tool for studying the effect of exercise on cortical plasticity. The aims of the study in non-disabled PwMS are: 1) a) to assess the presence of subclinical balance and walking impairments using wearable devices and multimodal gait analysis and b) to investigate cortical activity during exercise, 2) to define prognostic factors associated to disease progression and 3) to study the efficacy of physical activity in preventing the worsening of mobility and stimulating brain functional adaptation.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jul 2022

Typical duration for all trials

Geographic Reach
1 country

3 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2022

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

September 11, 2023

Completed
4 months until next milestone

First Posted

Study publicly available on registry

January 23, 2024

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 7, 2024

Completed
1.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

January 23, 2024

Status Verified

July 1, 2023

Enrollment Period

2 years

First QC Date

September 11, 2023

Last Update Submit

January 12, 2024

Conditions

Keywords

early phasenon-disabled

Outcome Measures

Primary Outcomes (1)

  • Six Minute Walk test (SMWT)

    Assesses distance in meters walked over 6 minutes as a sub-maximal test of endurance capacity.

    Baseline, Follow-up 1year, Follow-up 2year

Secondary Outcomes (3)

  • Concentration of oxygenated hemoglobin (Delta oxyHb)

    Baseline, Follow-up 1year, Follow-up 2year

  • Expanded Disability Status Scale (EDSS)

    Baseline, Follow up 1year, Follow up 2year

  • Regularity of gait

    Baseline, Follow-up 1year, Follow-up 2yearr

Other Outcomes (16)

  • Dual Task Cost

    Baseline, Follow-up 1year, Follow-up 2year

  • Dual-task Impact on Daily-living Activities Questionnaire (DIDA-Q)

    Baseline, Follow-up 1year, Follow-up 2year

  • Timed 25 foot walk (T25FWT)

    Baseline, Follow-up 1year, Follow-up 2year

  • +13 more other outcomes

Interventions

Observation of the natural course of the disease

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Participants will be recruited within Persons with Multiple Sclerosis attending the clinical centers for routine medical visits willing to participate to the study after the presentation of the information sheet.

You may qualify if:

  • Age \> 17 years
  • Stable disease course (without worsening over 1 point at the EDSS in the last 3 months)
  • Expanded Disability Status Scale (EDSS) \<2.5

You may not qualify if:

  • Major depression
  • Mini-Mental State Examination \< 27
  • Other cardiovascular or orthopedic diseases that interfere with physical exercise
  • Undefined or not confirmed diagnosis of MS (Polman criteria)
  • Progressive course of the disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Ospedale Binaghi ASL Cagliari

Cagliari, Italy

Location

IRCCS Ospedale San Raffele

Milan, 20100, Italy

Location

IRCCS Fondazione Don Carlo Gnocchi

Milan, 20148, Italy

Location

Related Publications (1)

  • Gervasoni E, Torchio A, Bertoni R, Chieffo R, Rocca MA, Pau M, Cocco E, Morozumi T, Filippi M, Cattaneo D, Rovaris M. Beyond EDSS: multidomain impairments are detectable and associated with walking disorders in low-disabled people with multiple sclerosis. J Neurol. 2025 May 18;272(6):404. doi: 10.1007/s00415-025-13128-7.

MeSH Terms

Conditions

Multiple Sclerosis

Interventions

Watchful Waiting

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System Diseases

Intervention Hierarchy (Ancestors)

Outcome Assessment, Health CareOutcome and Process Assessment, Health CareQuality of Health CareHealth Services Administration

Study Officials

  • Marco Rovaris, MD

    IRCCS Fondazione Don Carlo Gnocchi

    PRINCIPAL INVESTIGATOR
  • Raffaella Chieffo, MD

    IRCCS Ospedale San Raffaele

    PRINCIPAL INVESTIGATOR
  • Eleonora Cocco, MD

    Ospedale Binaghi ASL Cagliari, Sardegna

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 11, 2023

First Posted

January 23, 2024

Study Start

July 1, 2022

Primary Completion

July 7, 2024

Study Completion

December 1, 2025

Last Updated

January 23, 2024

Record last verified: 2023-07

Locations